almagate has been researched along with Complication, Postoperative in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoguet, A; Parrish, RK | 1 |
| Capone, A; Quiram, P; Sund, N; Vinekar, A | 1 |
| Knip, MM; Välimäki, J | 1 |
| Inoue, M; Kadonosono, K; Kinoshita, S; Kobayakawa, S; Komori, H; Matsushima, H; Senoo, T; Sotozono, C; Suda, Y; Tanaka, K; Tochikubo, T | 1 |
| Bodaghi, B; Cochereau, I; Dumarcet, N; Goebel, F; Hajjar, J; Korobelnik, JF | 1 |
| Chen, TC; Englander, M; Kim, IK; Miller, JW; Paschalis, EI | 1 |
| Ducharme, JF; Filippopoulos, T; Krzystolik, MG; Loewenstein, JI | 1 |
| Chang, LK; Flaxel, CJ; Lauer, AK; Sarraf, D | 1 |
| Heimann, H; Meyer, CH; Ziemssen, F | 1 |
1 review(s) available for almagate and Complication, Postoperative
| Article | Year |
|---|---|
[Intravitreal injection. Monitoring to avoid postoperative complications].
Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cataract; Clinical Trials, Phase III as Topic; Endophthalmitis; Eye Hemorrhage; Female; Fetus; Hallucinations; Humans; Injections; Intraocular Pressure; Macular Degeneration; Mice; Paracentesis; Postoperative Complications; Pregnancy; Rabbits; Randomized Controlled Trials as Topic; Ranibizumab; Retinal Detachment; Uveitis; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
1 trial(s) available for almagate and Complication, Postoperative
| Article | Year |
|---|---|
Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: a prospective study.
Topics: Aged; Angiogenesis Inhibitors; Anterior Chamber; Aptamers, Nucleotide; Eye Pain; Female; Humans; Intraocular Pressure; Intravitreal Injections; Male; Pain Measurement; Paracentesis; Postoperative Complications; Prospective Studies; Tonometry, Ocular; Vascular Endothelial Growth Factor A | 2012 |
7 other study(ies) available for almagate and Complication, Postoperative
| Article | Year |
|---|---|
Unexpected hypotony after glaucoma drainage implant surgery associated with anti-vascular endothelial growth factor treatment.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Intravitreal Injections; Ocular Hypotension; Postoperative Complications; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant.
Topics: Aptamers, Nucleotide; Choroidal Neovascularization; Fluorescein Angiography; Humans; Infant; Injections; Male; Persistent Hyperplastic Primary Vitreous; Postoperative Complications; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy; Vitreous Body | 2010 |
Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Aqueous Humor; Bevacizumab; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Incidence; Intravitreal Injections; Japan; Middle Aged; Postoperative Complications; Ranibizumab; Retrospective Studies; Streptococcal Infections; Streptococcus oralis; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
[Intravitreal injections: AFSSAPS guide to good practice].
Topics: Aptamers, Nucleotide; Diabetic Retinopathy; Endophthalmitis; France; Humans; Intravitreal Injections; Macular Degeneration; Ophthalmologic Surgical Procedures; Postoperative Complications; Practice Guidelines as Topic; Retinal Diseases; Retinal Vein Occlusion; Societies, Medical | 2012 |
Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
Topics: Academic Medical Centers; Acute Disease; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Massachusetts; Postoperative Complications; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy.
Topics: Aptamers, Nucleotide; Chemotherapy, Adjuvant; Diabetic Retinopathy; Glaucoma Drainage Implants; Glaucoma, Neovascular; Gonioscopy; Humans; Injections; Iris; Lens Implantation, Intraocular; Male; Middle Aged; Neovascularization, Pathologic; Phacoemulsification; Postoperative Complications; Vitrectomy | 2006 |
RPE tears after pegaptanib treatment in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pigment Epithelium of Eye; Postoperative Complications; Retinal Perforations; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2007 |